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In patients with multiple sclerosis (MS) non-communicating syringomyelia (NCS) has been described as an
incidental finding in case studies and small case series. NCS in MS patients commonly leads to uncertainty
particularly as the clinical picture of NCS is variable and surgical therapy may be considered.Up to date little
is known about the prevalence and clinical importance of NCS in MS. We report the imaging and clinical
characteristics of NCS formations in nine MS patients from a 1 year follow-up study in a representative group
of 202 MS (4.5%) patients. Brain and spinal cord MRI was performed as part of a genetic study. NCS did
commonly extend the central canal and the cord was slightly distended at the level of the syrinx.The cord and
syrinx showed no tendency to change in size or shape over 1 year. Despite thorough search into the clinical
history and current clinical status no definite but only minimal indications of symptoms potentially related to
the NCS were found.We confirm that NCS may occur in MS patients with spinal cord pathology. It can be a
subtle finding without clinical correlates. Syrinx formations are more likely to be a consequence of MS cord
pathology than a coincidental finding.
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Introduction
Syringomyelia describes a cavitary enlargement of the spinal
cord, which may occur as one of three types (Milhorat
et al., 1995) (i) dilations of the central canal that com-
municate with the fourth ventricle; (ii) non-communicating
dilations of the central canal that arise below a syrinx free
segment of the cord and (iii) extracanalicular cavitations in
the parenchyma that do not involve the central canal. The
aetiology of syringomyelia is manifold and one can dis-
tinguish between symptomatic and congenital-idiopathic
types. The latter is often associated with the Chiari malfor-
mations, basilar impression, Dandy-Walker cysts and sub-
occipital encephalocele (Barnett et al., 1973; Metcalfe, 1992;
Anson et al., 1997; Parker et al., 1999). The symptomatic
forms include intramedullary neoplasms and post-traumatic
cavitations, which usually manifest some years after the
cord injury (Reddy et al., 1989). Furthermore, syrinx
formations have been noted as a post-inflammatory
phenomenon after basilar arachnoiditis (e.g. tuberculous
meningitis), aseptic inflammatory processes or surgery
(Barnett et al., 1973; Caplan et al., 1990).
In patients with multiple sclerosis (MS) non-
communicating syringomyelia (NCS) has been described in
various reports on small case series or case studies, one of
them having access to a post-mortem analysis of pathological
detail in the spinal cord (Kwee and Nakada, 1985; Ransohoff
et al., 1990; Milhorat et al., 1992; Solaro et al., 1999; Sotgiu
et al., 1999, 2001; Matsuda et al., 2001; Charles et al., 2004).
To date the relationship of NCS in MS and its prognosis is
not well understood. The incidental finding of NCS is more
common today with wider availability of whole cord MRI and
leads usually to uncertainty particular as the clinical picture of
NCS is variable and surgical therapy may be considered.
We had the opportunity to investigate the clinical and
MRI characteristics of NCS in a follow-up study of a cohort
of 202 MS patients as part of a phenotype-genotype study.
doi:10.1093/brain/awn068 Brain (2008), 131, 1776^1782
 The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Methods and Materials
Patients
All patients included were participants in an ongoing study on
the pheno-genotypic characterization of MS. A total of 259 MS
patients (181 women, 78 men) were recruited from our MS out-
patient clinic over 1 year. Of those patients, 202 (140 women, 62
men; 20- to 67-years-old) had complete MRI assessment including
brain and spinal cord MRI at baseline and at year 1. The remain-
ing 50 patients were not included for the lack of the complete
MRI assessment. At the time, all patients were assessed clinically
with a standardized neurological examination and a comprehen-
sive disease history. At the time of the follow-up visit 12 months
after baseline NCS was known and the clinical history and neuro-
logical examination focused on potential clinical manifestations
of NCS (e.g. pain syndromes, dissociated sensory loss). Of the 202
patients, 147 had relapsing-remitting MS (RRMS) disease course,
39 secondary progressive MS (SPMS) and 10 primary progressive
MS (PPMS). Six patients had the diagnosis of a clinically isolated
syndrome (CIS). The mean disease duration was 14 years, the
Expanded Disability Status Scale (EDSS) ranged from 0 to 7.5. All
patients were clinically stable. Patients having an acute relapse
were not examined and the MRI scan was postponed at least
30 days after the last dose of steroid treatment. Informed consent
was obtained in writing from all participating patients, in accor-
dance with the institution’s medical ethics committee approval.
In the nine patients with a syrinx an additional laboratory test
for anti-aquaporin-4 antibodies was performed to test for
neuromyelitis optica.
MRl
Brain and cord MRI was obtained in a single examination on a 1.5T
MRI system, MAGNETOM Avanto (Siemens Medical Solutions,
Erlangen, Germany). The brain MRI protocol included transverse
3mm proton density (PD)-weighted, T2-weighted and T1-weighted
sequences before and after single dose gadolinium application.
The spinal cord scan took place immediately after brain MRI
within the same scanning session. The delay between a single dose
gadolinium contrast injection for the brain MRI and the acquisi-
tion of sagittal images was 10min. For theoretical reasons, the
previous injection of the contrast agent might have shortened
the transverse relaxation time in pathology and thereby reduced
the sensitivity of PD- and T2-weighed sequences. This was not
observed in previous and subsequent diagnostic examinations,
when this potential influence was considered in particular. In
order to cover the large area of the whole spinal canal from the
foramen magnum to the sacral vertebrae two separate sets of
images were generated with two FOVs of 350 350mm2 size
(including 50% phase oversampling in head–feet direction to
avoid aliasing), the top part showing the cranio-cervical junction
up to the 9th thoracic vertebral body and the caudal set of images
covering the spine from 9th thoracic vertebra downwards to the
first sacral vertebra. In a post-processing step on the console by
manufacturer provided software, the two sagittal images were
distortion corrected and fused to demonstrate the whole spine.
Sagittal and transverse PD- and T2-weighted turbo-spin-echo
sequences were acquired with multi-array-coils and parallel imaging
techniques. Two sagittal sequences with PD [TR/TE 2000ms/23ms,
echo train length (ETL) 7, iPAT-factor 2, two averages, acquisition
time (TA) 2:40min] and T2-weighting (TR/TE 4440ms/102ms, ETL
25, iPAT 2, TA 2 : 32min) were obtained, with two overlapping FOVs
of 350 350mm2 resulting in a voxel size of 1.0 0.8 3mm.
Subsequently, two sets of 60 transverse 6mm PD-/T2-weighted slices
of the entire spinal cord were acquired using a dual-echo turbo-spin-
echo sequence: TR/TE1/TE2 2120/9.9/89ms, 2 NEX, ETL 7, iPAT 2,
1.1 0.5 6mm resolution, TA 4:51min. The transverse slices were
prescribed graphically in a standardized way (Fig. 1): four stacks,
each with 12–19 transverse slices were placed perpendicular to
the cord manually adjusted along the anatomic course of the cord
from the foramen magnum to the conus of the SC. The parallel
imaging factor was 2 for the above sequences. The total acquisition
time of the whole spinal cord in two planes was 11min.
The patients in whom a syrinx was identified underwent an
additional sagittal pre-contrast and a sagittal (TR/TE 676ms/13ms)
and transverse post-contrast (single dose gadoterate meglumine)
Fig. 1 Sagittal T2-weighted image of the spinal cord showing
graphical planning of transverse slices covering the whole cord.
Four stacks of slices are placed perpendicular to the cord at
the respective levels.
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T1-weighted scan (TR/TE 684ms/11ms) in order to exclude further
abnormalities.
Data analysis
A standardized qualitative reporting scheme for the presence
and location of intrinsic cord changes (e.g. focal lesions, diffuse
changes, atrophy) and other pathology was employed by a con-
sensus reading of two experienced readers. In the nine patients
with a syrinx formation, previous medical charts and MRI (when
available) were also considered. Digital images of those patients
were further analysed on a dedicated Siemens work station.
Results
MRI analysis identified in 9/202 (4.5%) MS patients syrinx
formations in the spinal cord (Fig. 2). Digital quantitative
analysis results are given in Table 2.
Clinical findings (Table 1)
A diagnosis of MS had been established including positive
oligoclonal bands on CSF analysis. Patients presented with a
wide range of symptoms and mean EDSS was 2.6 (0–6.5).
Careful clinical examination showed in none of the cases
dissociated sensory loss, a typical pain syndrome or
suggested a focal functional deficit arising from the area
of the syrinx level. Please see Table 2 for patient data.
Patient 7 had been diagnosed with MS 8 years earlier and
had undergone hemilaminectomy at the level of the 5th
lumbar vertebral body for radicular decompression after
disc protrusion and sensory-motor disturbance. A syrinx
like formation was found in this patient in the thoracic
cord at the level of the 8th thoracic vertebral body. In none
of the patients a previous history of trauma, cord surgery,
or previous intervention besides the lumbar puncture for
diagnostic CSF analysis were identified. Acute relapses were
noted in 3/9 patients in the 12 month prior to the baseline
scan. In 5/9 patients an acute relapse was recorded in the
12 month interval between baseline and follow-up MRI.
All acute relapse symptoms subsided and no permanent
change of the EDSS was present at the clinical 12 month
follow-up assessment. The nine patients with a syrinx were
negative for anti-aquaporin-4 antibodies.
MRI (Fig. 2,Table 2)
In nine MS patients with syrinx formations in the spinal cord,
the brain MRI demonstrated typical MS brain lesions, while
patients 2 and 7 showed only 1, respectively, 4 brain lesions.
There was no overt brain atrophy or pathological contrast
enhancement. Proton density- and T2-weighted spinal cord
MRI demonstrated evidence of focal hyperintense lesions,
but no diffuse T2-hyperintense abnormalities or atrophic cord
changes. Five patients showed slight degenerative changes of
the vertebral column, but not causing cord compression or
relevant narrowing of the CSF space. None of the patients
showed abnormalities of the cranio-cervical junction or
indications for abnormality within the CSF space. The
syrinx formations were located either in the thoracic or
lumbar cord (Fig. 3). The cross-sectional location of the syrinx
appeared to be in the position of the central canal as inter-
preted from the sagittal and transverse images in all cases.
One patient showed three non-communicating cavitations at
different levels of the cord separated by syrinx-free segments,
while 8/9 had a single syrinx. The extension of each cavity
ranged from less than one vertebral body up to more than
five vertebral bodies (2.5–17 cm length). The cavity diameter
ranged from 15 to 50mm. On sagittal images the cord
appeared slightly distended in patients 1–3 and more
pronounced so in patients 4–9.
Concomitant MS cord lesions were present in all
patients. While patient 2 had only one lesion below the
syrinx, the other patients had lesions above the syrinx
whilst both lesions above and below the syrinx were noted
in three patients (6, 8 and 9). In three patients (1, 7 and 9)
cord lesions were present in proximity to the syrinx, close
to the cranial (1, 7) or caudal end of the syrinx. There was
Fig. 2 T2-weighted images of the nine MS patients with syringomyelia in sagittal and transverse perspective. Syrinx formations
vary in length and cross-sectional diameter, some show a slightly distending effect on the cord.
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Table 1 Demographic and clinical information of the nine MS patients with syrinx formations
Patient no. 1 2 3 4 5 6 7 8 9
Sex/age (years) m, 38 w, 35 m, 45 w, 36 w, 55 m, 54 w, 61 w, 56 w,34
Disease course RRMS RRMS RRMS RRMS RRMS SPMS SPMS RRMS RRMS
Disease duration
(years)
3 8 7 14 8 28 8 8 14
CSF oligoclonal bands Positive Positive Positive Positive Positive Positive Positive Positive Positive
Anti-aquaporin-4-
antibody titer
Negative Negative Negative Negative Negative Negative Negative Negative Negative
Presenting symptoms Hypaesthesia
left buttock,
hip and thigh
Hypaesthesia
left sided
trunk + leg
Weakness left leg,
urgency
Paraesthesia in
all limbs,
weakness
left arm
Urgency Diplopia Hypesthesia both
hands
Diplopia Paraesthesia of
both legs
Subsequent symptoms
(potentially cord related)
Slight urgency ^ Hypaesthesia leg,
transient
weakness right leg
Slight weakness
of left limbs,
dysaesthesia
left trunk
Slight weakness
left leg
Progressive spastic
tetraparesis
Frequent urinary
tract infection,
retention
Slight spasticity
of left leg gait,
transient
weakness
right leg
Transient dys- and
hypaesthesia below
the level of
thoracic dermatome 4
Current symptoms
(potentially
cord related)
No symptoms No symptoms Slight urgency,
imbalance
No symptoms Motor and cognitive
fatigability, urgency
spastic tetraparesis,
urgency
Paraesthesias
both hands,
fatigability,
urgency
Weakness right
arm + leg, motor
fatigability, urgency
no symptoms
Current findings
(potentially
cord related)
No Sc-symptoms No Sc-symptoms Bilateral
pallhypaesthesia
No Sc-symptoms Pyramidal weakness
of both legs, bilateral
pallhypaesthesia,
urgency, retention
spastic tetraparesis Bilateral
pallhypaesthesia
Motor fatigability,
pallhypaesthesia
Bilateral
pallhypaesthesia
No. of relapses 12 month
prior to first scan
^ ^ ^ 1 ^ ^ ^ 1 2
No. of relapses between
baseline and fu scan
1 1 2 1 ^ ^ ^ 2 ^
EDSS 0 1.5 2 2.5 3 6.5 2.5 4 1.5
Current therapy Interferon b-1a Glatiramer
acetate
Interferon b-1a Interferon b-1b Interferon b-1a ^ Interferon b-1b Interferon b-1b Interferon b-1a
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Table 2 MR findings in nine patients with syrinx formations
Patient no. 1 2 3 4 5 6 7 8 9
Size in length (cm) A: 4; B: 3; C: 10.5 2.5 9 3.5 3.5 17 15 4.5 4.5
Location according to
the level of vertebral bodies
A: TH 4/5; B: TH 7/8; C: TH 9 ^ L1 TH 3/4 TH 5^9 TH 5/6 TH 6/7 TH 5^10 TH 8^L1 TH 8^9 TH 5^7
Maximum cross-sectional area of
the syrinx (mm2)
A: 2.3; B: 2.6; C: 8.4 28.3 9.8 4.6 2.0 4.6 4.9 3.5 3.2
Cord cross-section above
the syrinx (mm2)
A: 58.3; B: 52.8; C: 54.2 44.7 43.6 44.7 41.3 51.6 49.3 39.8 40.1
Cord cross-section at
the level of the syrinx (mm2)
A: 55.4; B: 49.9; C: 71.8 128.1 56.8 52.5 44.7 48.2 57.7 43.0 49.3
MS lesions in the proximity to the syrinx according to:
a) the top of the syrinx ^ ^ ^ ^ ^ ^ 1 ^ ^
b) the level of the syrinx 1 ^ ^ ^ ^ ^ ^ ^ 1
c) the bottom of the syrinx ^ ^ ^ ^ ^ ^ ^ ^ 1
Additional cord changes (acc. to the level of vertebral bodies)
No. of focal lesions (total) 6 ^ 4 3 3 8 1 5 5
a) cervical 5 ^ 3 3 3 5 1 4 3
b) thoracic 1 ^ 1 ^ ^ 3 ^ 1 2
DiffuseT2-hyperintensities ^ ^ ^ ^ ^ ^ ^ ^ ^
Changes of the syrinx formation
after 1 year f/u
No No No No No No No No No
Brain
T2 lesion volume (mm
3) 826 40 2552 15356 17170 4020 14 6145 337
T1 volume (mm
3) 171 0 512 4523 3070 1948 0 2160 103
No. of Gd+ lesions 0 0 0 0 0 0 0 0 0
Pat. No. 1 shows three separate syrinx formations at different cord levels. TH=thoracic vertebral body; L= lumbar vertebral body.
Gd+=contrast enhancement (Dotarem).
Fig. 3 Sagittal and transverse PD- (A) and T2-weighted (B) images of the entire cord of patient 1. Three focal lesions (arrows) in the
cervical cord are more strongly contrasted on PD images (A) (see magnification on the left) whereas the syrinx formations at the thoracic
and lumbar levels are more strongly contrasted on theT2-weighted images (B). The transverse plane (C) demonstrates the location of the
syrinx in relation to cord cross-section.
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no uniform pattern in regard to the size or cross-sectional
location of those lesions.
The additional pre- and post-contrast T1-weighted MRI,
which was only performed in the nine patients with the
syrinx, did not show pathological contrast enhancement or
any additional pathology. Compared with the T2-weighted
images it was more difficult to acertain the small hypo-
intense syrinx on the T1-weighted images due to the lower
contrast between cord tissue and syrinx.
Follow-up spinal cord MRI after 1 year in all cases demon-
strated no change of the MR appearance of the above
described cord findings. Both the previous history and the
follow-up MRI revealed no indication of cord neoplasms.
Discussion
Syrinx formations in MS patients have been described
previously in case reports as incidental findings. This study
offers a broad view at NCS in MS patients by examining a
relatively large representative cohort with a wide range of
clinical characteristics, who were originally recruited for a
genetic study to represent a wide spectrum of MS. As
demonstrated by MRI, the size of syrinx formations is
variable and frequently NCS is a rather subtle finding, but
the technology used in this study (parallel imaging in
combination with multi-array-coils) allowed to ascertain
the NCS by using T2-weighted sequences in two imaging
planes (Noebauer-Huhmann et al., 2007). While truncation
artefact is a common source of high signal bands on sagittal
T2-weighted images (Taber et al., 1998) that can obscure a
syrinx pathology the presence of NCS was confirmed on the
axial cord MRI in this study.
We found NCS in 4.5% of our MS cohort. Compared
with this data estimations of the prevalence of NCS in the
normal population are very difficult. In a study of the
whole cord Thorpe and colleagues did not find any intrinsic
cord abnormality in 50 normal controls (Thorpe et al.,
1993), which is very much the experience from diagnostic
MRI in patients investigated for degenerative disc disease.
Given the potential lack of obvious clinical symptoms
related to the syrinx, one may assume that syringomyelia
may remain undetected in healthy individuals. However, in
epidemiological studies the prevalence of syringomyelia
ranges from 8.4/1 00 000 to 0.9/10 000 (Brewis et al., 1966;
Ferrero Arias and Pilo Martin, 1991). In MS patients,
demyelinating lesions of the cord regularly show some
evolution over time, however, the NCS formations in this
study were unchanged in all cases over the 1 year follow-up
period. In two patients, who had undergone previous spinal
MRI exams, NCS was stable even over 5 years follow-up.
In this regard, the syrinx was not a transient phenomenon
but a rather stable MR finding and its frequency in our
cohort may be useful to estimate the prevalence in MS.
The nine patients with syrinx formations had relapsing
forms of MS with variable disease durations ranging from
early RRMS to SPMS with superimposed relapses. There were
no peculiar clinical histories or uncommon clinical findings
suggesting another differential diagnosis or a second pathol-
ogy. In particular, neuromyelitis optica (NMO) needs to be
considered in patients with an uncommon cord pathology
and a diagnosis of inflammatory-demyelinating disease.
However, our patients all were initially diagnosed with MS
and they were negative for anti-aquaporin-4 antibodies. In the
absence of both anti-aquaporin-4 antibodies and typical
extensive multilevel cord lesions it appears not likely that the
patients were initially misdiagnosed and NMO was the
underlying cause. So far clinical and radiological descriptions
of NMO do not include a syrinx as an early or late finding.
Furthermore, common causes of syringomyelia were excluded
and there were no indications of cord neoplasm. In contrast to
some previous case reports, our patients were either asymp-
tomatic or not obviously clinically affected by the NCS.
Patients 3, and 5–9 showed symptoms possibly due to spinal
cord lesions but no typical clinical presentations of syringo-
myelia. However, a contribution of the syrinx to the clinical
presentations would be very difficult to exclude. In keeping
with our findings, a recent literature review pointed out, that
in most reported cases syringomyelia has been an incidental
finding when patients underwent MRI not for clinically
suspected syrinx but spinal cord involvement of MS (Larner
et al., 2002).
We assume that NCS is not a coincidental finding but
associated with spinal cord involvement in MS. The lower
prevalence of NCS in the normal population speaks in favour
of a causal relationship of inflammatory-demyelinating
pathology and NCS. This being said, NCS did not appear to
be strictly related to some specific location or detectable cross-
sectional topographical relationship to demyelinating cord
lesions. Most MS lesions in our patients were found in the
cervical cord, but the NCS were located in the thoracic or
lumbar cord. As reviewed in recent papers the fluid accu-
mulation in the syrinx probably represents lack of physiolo-
gical CSF drainage in the central canal (Ball and Dayan, 1972;
Milhorat et al., 1994; Kleinschmidt-DeMasters and Newell,
1996). Residual CSF signal can be observed regularly in the
position of the central canal in the normal cord. The mecha-
nism for the formation of a syrinx in MS patients is uncertain,
but one could hypothesize, that residual cord tissue changes
might alter normal CSF drainage from the central canal.
However, there was no uniform spatial relationship of cord
lesions to the NCS that could confirm such a hypothesis. We
conclude that, in the presence of other cord and brain lesions
typical for MS, a syrinx can be due to MS. However, as long as
the exact mechanism of the development of such small cavities
is uncertain other causes should be considered.
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